Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is needed

Affiliations

¹ Nutrition and Metabolism, Faculty of Medicine, University of Southampton, Southampton, UK c.d.byrne@soton.ac.uk.
² Endocrinology and Metabolism, University of Verona Department of Medicine, Verona, Italy.

^# Contributed equally.

Comment

Christopher D Byrne et al. Gut. 2022 Sep.

. 2022 Sep;71(9):1695-1696.

doi: 10.1136/gutjnl-2021-325965. Epub 2021 Sep 11.

¹ Nutrition and Metabolism, Faculty of Medicine, University of Southampton, Southampton, UK c.d.byrne@soton.ac.uk.
² Endocrinology and Metabolism, University of Verona Department of Medicine, Verona, Italy.

^# Contributed equally.

No abstract available

Keywords: cardiovascular disease; diabetes mellitus; fatty liver; nonalcoholic steatohepatitis.

Conflict of interest statement

Competing interests: None declared.

Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
Simon TG, Roelstraete B, Hagström H, Sundström J, Ludvigsson JF. Simon TG, et al. Gut. 2022 Sep;71(9):1867-1875. doi: 10.1136/gutjnl-2021-325724. Epub 2021 Sep 6. Gut. 2022. PMID: 34489307